Saturn V Capital Management LLC Portfolio Holdings

Saturn V Capital Management LLC

  • $247 Billion
  • Q2 2025

Saturn V Capital Management LLC has filed its 13F form on August 13, 2025 for Q2 2025 where it was disclosed a total value porftolio of $247 Billion distributed in 24 stocks.

Among their holdings, we can observe that their the top five positions include companies like: Jazz Pharmaceuticals PLC with a value of $22B, Disc Medicine Inc with a value of $21B, Amylyx Pharmaceuticals, Inc. with a value of $20.9B, Vaxcyte, Inc. with a value of $17.7B, and Cogent Biosciences, Inc. with a value of $16.5B.

Examining the 13F form we can see an increase of $48.6B in the current position value, from $198B to 247B.

Saturn V Capital Management LLC is based out at Austin, TX

Below you can find more details about Saturn V Capital Management LLC portfolio as well as his latest detailed transactions.

Portfolio value $247 Billion
Healthcare: $190 Billion

Stock Holdings Table

Stock Market Cap. Holding Value (Reported) # of Shares. Last Trade Trade History
$7.1B
$22 Billion 8.9% of portfolio
206,952
Q2 2025 New
Disc Medicine Inc
-
$21 Billion 8.5% of portfolio
-
Q2 2025 Reduced 23.56%
$481M
$20.9 Billion 8.47% of portfolio
3,260,570
Q2 2025 Added 34.38%
$1.78B
$17.7 Billion 7.17% of portfolio
544,221
Q2 2025 Added 134.28%
$760M
$16.5 Billion 6.69% of portfolio
2,297,524
Q2 2025 Added 55.24%
$748M
$15.8 Billion 6.41% of portfolio
1,185,520
Q2 2025 Added 8.4%
Cg Oncology Inc
-
$15.3 Billion 6.18% of portfolio
-
Q2 2025 Added 1.55%
$2.24B
$14.7 Billion 5.94% of portfolio
468,364
Q2 2025 Added 13.21%
$602M
$13.9 Billion 5.62% of portfolio
1,455,429
Q2 2025 New
$2.04B
$13.7 Billion 5.56% of portfolio
290,784
Q2 2025 Reduced 15.43%
$2.93B
$11.8 Billion 4.78% of portfolio
224,260
Q2 2025 Reduced 30.61%
$1.61B
$10.4 Billion 4.22% of portfolio
793,327
Q2 2025 Added 76.81%
Lenz Therapeutics Inc
-
$10 Billion 4.07% of portfolio
-
Q2 2025 New
$12.3B
$7.31 Billion 2.96% of portfolio
58,181
Q2 2025 New
$961M
$6.76 Billion 2.74% of portfolio
728,576
Q2 2025 Added 21.8%
$10.9B
$6.59 Billion 2.67% of portfolio
38,191
Q2 2025 Reduced 80.83%
Abivax Sa
-
$4.76 Billion 1.93% of portfolio
-
Q2 2025 Added 12.58%
$734M
$4.69 Billion 1.9% of portfolio
500,551
Q2 2025 Reduced 51.93%
-
$4 Billion 1.62% of portfolio
-
Q2 2025 Added 89.68%
Contineum Therapeutics Inc
-
$1.27 Billion 0.51% of portfolio
-
Q2 2025 Reduced 43.07%
$259M
$1.2 Billion 0.49% of portfolio
128,917
Q2 2025 New
$301M
$710 Million 0.29% of portfolio
62,793
Q2 2025 Reduced 75.38%
$201M
$201 Million 0.08% of portfolio
34,737
Q2 2025 Reduced 95.26%

Summary

  • Portfolio
  • No. of Stocks 24
  • Current Value $247 Billion
  • Prior Value $198 Billion
  • Filing
  • Period Q2 2025
  • Filing Date August 13, 2025
  • Form Type 13F-HR
  • Activity in Q2 2025
  • New Purchases 5 stocks
  • Additional Purchases 10 stocks
  • Sold out of 0 stocks
  • Reduced holdings in 9 stocks
Track This Portfolio

Track Saturn V Capital Management LLC Portfolio

Follow Saturn V Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Saturn V Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Saturn V Capital Management LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email